MEGen: A Physiologically Based Pharmacokinetic Model Generator

MEGen: A Physiologically Based Pharmacokinetic Model Generator

Physiologically based pharmacokinetic models are being used in an increasing number of different areas. These not only include the human safety assessment of pharmaceuticals, pesticides, biocides and environmental chemicals but also for food animal, wild mammal and avian risk assessment. The value o...

Full description

Bibliographic Details
Main Authors:	George D Loizou, Alex eHogg
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2011-11-01
Series:	Frontiers in Pharmacology
Subjects:	database PBPK risk Toxicity assessment equation
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2011.00056/full

Similar Items

Physiologically Based Pharmacokinetics Model in Pregnancy: A Regulatory Perspective on Model Evaluation
by: Paola Coppola, et al.
Published: (2021-06-01)

Prediction of the pharmacokinetics, pharmacodynamics and efficacy of a monoclonal antibody, using a physiologically based pharmacokinetic FcRn model.
by: Manoranjenni eChetty, et al.
Published: (2015-01-01)

Development, Testing, Parameterization, and Calibration of a Human Physiologically Based Pharmacokinetic Model for the Plasticizer, Hexamoll® Diisononyl-Cyclohexane-1, 2-Dicarboxylate Using In Silico, In Vitro, and Human Biomonitoring Data
by: Kevin McNally, et al.
Published: (2019-11-01)

The Use of a Physiologically Based Pharmacokinetic Modelling in a “Full-Chain” Exposure Assessment Framework: A Case Study on Urban and Industrial Pollution in Northern Italy
by: Lorenzo Vaccari, et al.
Published: (2020-11-01)

Physiologically based pharmacokinetic modelling of the central nervous system : strategies for drug development
by: Ball, Kathryn
Published: (2014)

A computational investigation of the ventilation structure and maximum rate of metabolism for a physiologically based pharmacokinetic (PBPK) model of inhaled xylene
by: Karen A Yokley, et al.
Published: (2019-02-01)

Physiologically Based Pharmacokinetic Modelling for Nicotine and Cotinine Clearance in Pregnant Women
by: Basile Amice, et al.
Published: (2021-07-01)

Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials
by: Wells Utembe, et al.
Published: (2020-06-01)

A Workflow for Global Sensitivity Analysis of PBPK Models
by: Kevin eMcNally, et al.
Published: (2011-06-01)

A Computational Workflow for Probabilistic Quantitative in Vitro to in Vivo Extrapolation
by: Kevin McNally, et al.
Published: (2018-05-01)

Unravelling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
by: Xiaoxia eYang, et al.
Published: (2015-01-01)

Development, Testing, Parameterisation and Calibration of a Human PBPK Model for the Plasticiser, Di-(2-propylheptyl) Phthalate (DPHP) Using in Silico, in vitro and Human Biomonitoring Data
by: Kevin McNally, et al.
Published: (2021-09-01)

Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development
by: Abdul Naveed Shaik, et al.
Published: (2019-02-01)

A probabilistic model of human variability in physiology for future application to dose reconstruction and QIVIVE
by: Kevin eMcNally, et al.
Published: (2015-10-01)

The Application of Global Sensitivity Analysis in the Development of a Physiologically Based Pharmacokinetic Model for m-Xylene and Ethanol Co-Exposure in Humans
by: George D Loizou, et al.
Published: (2015-06-01)

Physiologically-Based Pharmacokinetic Model for Ertapenem
by: Forbes, Whitney
Published: (2014)

A Physiologically-Based Pharmacokinetic Model for Vancomycin
by: White, Rebekah
Published: (2015)

Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics
by: Zaril Zakaria, et al.
Published: (2018-01-01)

Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model
by: Cheng Cui, et al.
Published: (2020-07-01)

Statistical Estimation of Physiologically-based Pharmacokinetic Models: Identifiability, Variation, and Uncertainty with an Illustration of Chronic Exposure to Dioxin and Dioxin-like-compounds.
by: Thompson, Zachary John
Published: (2012)

Prediction of the pharmacokinetics and pharmacodynamics of topiroxostat in humans by integrating the physiologically based pharmacokinetic model with the drug-target residence time model
by: Zhiqiang Luo, et al.
Published: (2020-01-01)

Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles
by: Carlander U, et al.
Published: (2016-02-01)

Prospects and limitations of physiologically-based pharmacokinetic modelling for cross-species extrapolation
by: Lars Kuepfer
Published: (2019-07-01)

Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients
by: Kalam MN, et al.
Published: (2021-03-01)

Prediction of Deoxypodophyllotoxin Disposition in Mouse, Rat, Monkey and Dog by Physiologically-based Pharmacokinetic Model and the Extrapolation to Human
by: Yang Chen, et al.
Published: (2016-12-01)

A Physiologically-Based Pharmacokinetic Model for the Antibiotic Levofloxacin
by: McCartt, Paezha M
Published: (2016)

Evaluation of Placental Transfer and Tissue Distribution of cis- and Trans-Permethrin in Pregnant Rats and Fetuses Using a Physiological-Based Pharmacokinetic Model
by: Stéphane Personne, et al.
Published: (2021-09-01)

Physiologically Based Pharmacokinetic (PBPK) model for biodistribution of radiolabeled peptides in patients with neuroendocrine tumours
by: Viktor Popov, et al.
Published: (2016-07-01)

Quantitative Analysis of Tozadenant Using Liquid Chromatography-Mass Spectrometric Method in Rat Plasma and Its Human Pharmacokinetics Prediction Using Physiologically Based Pharmacokinetic Modeling
by: Byeong ill Lee, et al.
Published: (2019-04-01)

An integrated exposure and pharmacokinetic modeling framework for assessing population-scale risks of phthalates and their substitutes
by: Yaoxing Wu, et al.
Published: (2021-11-01)

A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications
by: Sundus Khalid, et al.
Published: (2021-09-01)

Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim
by: Sumit Basu, et al.
Published: (2020-06-01)

Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients
by: Lukas Kovar, et al.
Published: (2020-09-01)

Clopidogrel Pharmacokinetics in Malaysian Population Groups: The Impact of Inter-Ethnic Variability
by: Zaril H. Zakaria, et al.
Published: (2018-07-01)

Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics
by: Jeffry Adiwidjaja, et al.
Published: (2020-01-01)

Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic model
by: Memoona Rashid, et al.
Published: (2020-07-01)

Physiologically-based pharmacokinetic simulations in pharmacotherapy: selection of the optimal administration route for exogenous melatonin
by: Adriana Savoca, et al.
Published: (2019-02-01)

Prediction of a Therapeutic Dose for Buagafuran, a Potent Anxiolytic Agent by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Starting from Pharmacokinetics in Rats and Human
by: Fen Yang, et al.
Published: (2017-10-01)

Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE)
by: Hsuan Ping Chang, et al.
Published: (2021-03-01)

Physiologically-based pharmacokinetic modeling of tamoxifen and its metabolites in women of different CYP2D6 phenotypes provides new insight into the tamoxifen mass balance
by: Kristin eDickschen, et al.
Published: (2012-05-01)